Reply to "Weekly paclitaxel in elderly breast cancer patients", by C. Smorenburg et al. (Ann Oncol 2005; 16: 1979)

Smorenburg and ten Tije rightly suggest that the higher than previously reported rate of cardiotoxicity observed in the GIOGer study on weekly paclitaxel in elderly patients [1Go] may be correlated with previous anthracycline-containing adjuvant chemotherapy received by the patients. Development of both clinical and subclinical long-term cardiotoxicity occurred slightly more frequently in patients previously treated with anthracycline-containing regimens as compared with patients not treated with anthracyclines [2Go], as well as more frequently in patients who had received a high dose of anthracyclines as compared with those treated with a low dose of such drugs [3Go]. These data indicate that patients treated with anthracyclines may suffer cardiac damage, with a subsequent high risk of cardiac events. In our study, out of 46 patients who received weekly paclitaxel, 19 had received previous chemotherapy (15 as adjuvant only, one as neo-adjuvant only, and three as both neo-adjuvant and adjuvant). Of these, eight had never received anthracyclines, eight had been treated with epirubicin-containing regimens and three with mitoxantrone-based chemotherapy. As shown in Table 1, there was no relationship between previous chemotherapy and development of cardiac toxicity. Although the low number of events does not allow a potential role of previous anthracycline-containing chemotherapy to be completely ruled out as a risk factor for cardiotoxicity development, our results indicate that elderly patients receiving chemotherapy, because of the increased risk of cardiotoxicity related to both their age [4Go] and the frequent presence of other concomitant disease [5Go], should be monitored closely regardless of the previous adjuvant treatment received.


View this table:
[in this window]
[in a new window]
 
Table 1. Correlation between cardiotoxicity and previous adjuvant chemotherapy received by the patients

 
L. Del Mastro1,* and F. Perrone2

1 Department of Medical Oncology, National Cancer Research Institute, Genoa; 2 Clinical Trials Unit, NCI, Naples, Italy

* E-mail: lucia.delmastro{at}istge.it

References

1. Del Mastro L, Perrone F, Repetto L et al. Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatria (GIOGer). Ann Oncol 2005; 16: 253–258.[Abstract/Free Full Text]

2. Zambetti M, Moliterni A, Materazzo C et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. J Clin Oncol 2001; 19: 37–43.[Abstract/Free Full Text]

3. Bonneterre J, Rochè H, Kerbrat P et al. Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group. J Clin Oncol 2004; 22: 3070–3079.[Abstract/Free Full Text]

4. Venturini M, Michelotti A, Del Mastro L et al. Multicenter randomized controlled clinical trial to evacuate cardioprotection with dexrazoxane versus no cardioprotection in women receiving chemotherapy for advanced breast cancer. J Clin Oncol 1996; 14: 3112–3120.[Abstract/Free Full Text]

5. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339: 900–905.[Free Full Text]





This Article
Full Text (PDF)
All Versions of this Article:
16/12/1979-a    most recent
mdi387v1
E-letters: Submit a response
Alert me when this article is cited
Alert me when E-letters are posted
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Disclaimer
Request Permissions
Google Scholar
Articles by Del Mastro, L.
Articles by Perrone, F.
PubMed
PubMed Citation
Articles by Del Mastro, L.
Articles by Perrone, F.